Literature DB >> 7659105

Dystrophin-positive fibers in Duchenne dystrophy: origin and correlation to clinical course.

M Fanin1, G A Danieli, M Cadaldini, M Miorin, L Vitiello, C Angelini.   

Abstract

In 132 DMD muscle biopsies we investigated the presence of dystrophin-positive fibers and the relationship of dystrophin immunohistochemical pattern to the clinical severity of the disease. Reverted fibers were detected in 37% of patients; their prevalence increased significantly in each biopsy with age of patients. We suggest that reversion occurs in satellite cells, when muscle differentiation is completed. The longitudinal extent of dystrophin-positive domain spans a maximum length of 900 microns. No correlation was found between the presence of reverted fibers and the clinical severity of DMD, whereas a milder form of Duchenne dystrophy was observed in patients showing a faint reaction in all fibers. The occurrence of reverted fibers is independent of the type of gene mutation; however, a higher proportion of cases with reverted fibers was found among patients with gene duplications.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7659105     DOI: 10.1002/mus.880181007

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  17 in total

1.  Anti-dystrophin T cell responses in Duchenne muscular dystrophy: prevalence and a glucocorticoid treatment effect.

Authors:  Kevin M Flanigan; Katie Campbell; Laurence Viollet; Wei Wang; Ana Maria Gomez; Christopher M Walker; Jerry R Mendell
Journal:  Hum Gene Ther       Date:  2013-09       Impact factor: 5.695

2.  Inhibition of antigen presentation during AAV gene therapy using virus peptides.

Authors:  Wenwei Shao; Xiaojing Chen; Richard J Samulski; Matthew L Hirsch; Chengwen Li
Journal:  Hum Mol Genet       Date:  2018-02-15       Impact factor: 6.150

Review 3.  Molecular Therapies for Muscular Dystrophies.

Authors:  Ava Y Lin; Leo H Wang
Journal:  Curr Treat Options Neurol       Date:  2018-06-21       Impact factor: 3.598

4.  Revertant mosaicism: partial correction of a germ-line mutation in COL17A1 by a frame-restoring mutation.

Authors:  T N Darling; C Yee; J W Bauer; H Hintner; K B Yancey
Journal:  J Clin Invest       Date:  1999-05-15       Impact factor: 14.808

5.  In vivo PS-OCT needle probe scan of human skeletal muscle.

Authors:  Jeffrey M McBride; Michael J Hackmann; Sophia Nimphius; Barry Cense
Journal:  Biomed Opt Express       Date:  2022-02-14       Impact factor: 3.732

Review 6.  Somatic genetic rescue in Mendelian haematopoietic diseases.

Authors:  Patrick Revy; Caroline Kannengiesser; Alain Fischer
Journal:  Nat Rev Genet       Date:  2019-06-11       Impact factor: 53.242

7.  Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse.

Authors:  C J Mann; K Honeyman; A J Cheng; T Ly; F Lloyd; S Fletcher; J E Morgan; T A Partridge; S D Wilton
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

Review 8.  Old and new therapeutic developments in steroid treatment in Duchenne muscular dystrophy.

Authors:  Corrado Angelini; Enrico Peterle
Journal:  Acta Myol       Date:  2012-05

9.  Revertant fibers in the mdx murine model of Duchenne muscular dystrophy: an age- and muscle-related reappraisal.

Authors:  Sarah R Pigozzo; Lorena Da Re; Chiara Romualdi; Pietro G Mazzara; Eva Galletta; Sue Fletcher; Stephen D Wilton; Libero Vitiello
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

10.  A duchenne muscular dystrophy gene hot spot mutation in dystrophin-deficient cavalier king charles spaniels is amenable to exon 51 skipping.

Authors:  Gemma L Walmsley; Virginia Arechavala-Gomeza; Marta Fernandez-Fuente; Margaret M Burke; Nicole Nagel; Angela Holder; Rachael Stanley; Kate Chandler; Stanley L Marks; Francesco Muntoni; G Diane Shelton; Richard J Piercy
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.